Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy. (Q42503806)

From Wikidata
Revision as of 19:20, 13 March 2019 by Emijrpbot (talk | contribs) (‎Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw)
Jump to navigation Jump to search
scientific article
Language Label Description Also known as
English
Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy.
scientific article

    Statements

    title
    Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    11334846
    retrieved
    1 November 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q42503806&oldid=882185895"